Document Detail


Vitamin D Supplementation and the Effects on Glucose Metabolism During Pregnancy: A Randomized Controlled Trial.
MedLine Citation:
PMID:  24760259     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVEVitamin D deficiency in pregnancy is associated with an increased risk of gestational diabetes mellitus (GDM) and neonatal vitamin D deficiency. We conducted a double-blind, randomized controlled trial of low-dose (LD) versus high-dose (HD) vitamin D supplementation to investigate the effects of vitamin D supplementation on glucose metabolism during pregnancy.RESEARCH DESIGN AND METHODSWomen with plasma 25-hydroxyvitamin D (25OHD) levels <32 ng/mL before 20 weeks' gestation were randomized to oral vitamin D3 at 5,000 IU daily (HD) (n = 89) or the recommended pregnancy dose of 400 IU daily (LD) (n = 90) until delivery. The primary end point was maternal glucose levels on oral glucose tolerance test (OGTT) at 26-28 weeks' gestation. Secondary end points included neonatal 25OHD, obstetric and other neonatal outcomes, and maternal homeostasis model assessment of insulin resistance. Analysis was by intention to treat.RESULTSThere was no difference in maternal glucose levels on OGTT. Twelve LD women (13%) developed GDM versus seven (8%) HD women (P = 0·25). Neonatal cord 25OHD was higher in HD offspring (46 ± 11 vs. 29 ± 12 ng/mL, P < 0.001), and deficiency was more common in LD offspring (24 vs. 10%, P = 0.06). Post hoc analysis in LD women showed an inverse relationship between pretreatment 25OHD and both fasting and 2-h blood glucose level on OGTT (both P < 0·001). Baseline 25OHD remained an independent predictor after multiple regression analysis.CONCLUSIONSHD vitamin D supplementation commencing at a mean of 14 weeks' gestation does not improve glucose levels in pregnancy. However, in women with baseline levels <32 ng/mL, 5,000 IU per day was well tolerated and highly effective at preventing neonatal vitamin D deficiency.
Authors:
Constance Yap; Ngai W Cheung; Jenny E Gunton; Neil Athayde; Craig F Munns; Anna Duke; Mark McLean
Related Documents :
14664329 - Specific roles of the obstetrician-gynecologist.
19626619 - The proform of eosinophil major basic protein: a new maternal serum marker for adverse ...
24321039 - Effect of cytochrome p-450 epoxygenase and hydroxylase metabolites on rat myometrium co...
12923859 - Hyperechogenic fetal bowel: a large french collaborative study of 682 cases.
24476649 - Pregnancy in women with glycogen storage disease ia and ib.
18243129 - Development of a chemical screening system using aqueorin-fused protein.
15483089 - Endocrine changes in full-term pregnancies and pregnancy loss due to energy restriction...
11163819 - Relationship of follicle numbers and estradiol levels to multiple implantation in 3,608...
21751969 - Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preecla...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-23
Journal Detail:
Title:  Diabetes care     Volume:  -     ISSN:  1935-5548     ISO Abbreviation:  Diabetes Care     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7805975     Medline TA:  Diabetes Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased Incorporation of Antiplasmin Into the Fibrin Network in Patients With Type 1 Diabetes.
Next Document:  Changes in Subcutaneous Fat Cell Volume and Insulin Sensitivity After Weight Loss.